survodutide is a GLP-1/glucagon dual agonist
Mller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschp MH
Kinetics and mechanisms of reactions catalyzed by immobilized lipases
Merck is advancing its metabolic disease portfolio by researching GLP-1 analogs and combination therapies that offer improved weight loss and glycemic control
It binds to and activates human GHRH receptors with a potency akin to endogenous GHRH
Traditional dieting often feels like a constant battle against your own biology